- For three months ended August 31, 2018, core investor relations and subscription sales generated $497,560, or 70 percent of CIIX’s $712,360 total revenue
- Warren Wang, CEO of CIIX, eyes greater FY2019 distribution of industrial hemp-based CBD products, both domestically and in China, for CBD Biotech enterprise
- SeeThruEquity, LLC, in update, sees CIIX as having upside potential if it can achieve renewed traction on investor relations and execute on cannabis and cryptocurrency strategies
ChineseInvestors.com, Inc.’s (OTCQB: CIIX) core businesses of investor relations and subscriptions drove 70 percent of its 1Q19 revenues, the company reported. It also had 70 percent higher YOY sales for its first quarter (http://ibn.fm/niMS4). At the same time, CIIX sees CBD Biotech, its wholly-owned foreign enterprise, delivering higher CBD product distribution in FY2019, both domestically and in China. It also reported an 800 percent increase in product sales led by ChineseHempOil.com, Inc. in 1Q19.
The CBD division, which includes CBD Biotech, Hemp Logic, Inc. and ChineseHempOil.com, Inc. (http://ibn.fm/fQa2J), is expected to deliver greater CBD product distribution due to larger marketing resources supplied by the company and an improved business, regulatory and political landscape in China, the company said. Prior, CIIX had also detailed plans to spin off its CBD division in the future.
CIIX presented at the National Investment Banking Association (NIBA) investment conference held at the Crowne Plaza Times Square hotel in New York City on October 31-November 1. It discussed its first quarter 2019 performance.
Wang of CIIX says that the company recorded sales of $2.35 million for FY2018, the 12 months ended May 31, 2018, up 41 percent compared to the prior year (http://ibn.fm/nO4Hd).
“CBD hemp sales in China continue to be the foundation of our focus. Our subscription services will continue to provide a steady revenue stream along with the new educational services covering the cryptocurrency market.” Wang said in a news release. “With increased marketing resources devoted to our industrial hemp-based CBD products, we anticipate a productive fiscal year 2019.”
CIIX in 1Q19 reported a YOY increase of $90,000 from its subscription revenues. Investor relations and subscriptions represent its business roots. CIIX is a diverse company with an international audience of Chinese-speaking investors. It is active in cryptocurrency education and the cannabis industry.
In an update, SeeThruEquity, LLC projected that CIIX is an investment opportunity with upside potential, if the company can provide renewed traction in its high margin investor relations services business and execute on its initiatives in both cannabis and cryptocurrency (http://ibn.fm/6P9rL).
For more information, visit the company’s website at www.ChineseInvestors.com
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.